Comparative in vitro and in vivo evaluation of lipid based nanocarriers of Huperzine A

International Journal of Pharmaceutics

Volumn 446, Issue 1-2, 2013, Pages 16-23

  Patel, Pratikkumar A ^a   Patil, Sushant C ^a   Kalaria, Dhaval R ^b   Kalia, Yogeshwar N ^b   Patravale, Vandana B ^a  

^a INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Alzheimer's disease; Elevated plus maze; Huperzine A; Nanostructured lipid carriers; Solid lipid nanoparticles; Transdermal delivery system

Indexed keywords

EXCIPIENT; HUPERZINE A; NANOCARRIER; SCOPOLAMINE; SOLID LIPID NANOPARTICLE;

ALZHEIMER DISEASE; AMNESIA; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIREFRINGENCE; CONTROLLED STUDY; DISPERSION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG PENETRATION; DRUG SAFETY; FEASIBILITY STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; INTERMETHOD COMPARISON; MICROEMULSION; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROCESS OPTIMIZATION; RAT; SHEAR STRESS; SKIN IRRITATION; VISCOSITY; ZETA POTENTIAL;

ADMINISTRATION, CUTANEOUS; ALKALOIDS; AMNESIA; ANIMALS; CHOLINESTERASE INHIBITORS; DRUG CARRIERS; DRUG STABILITY; GELS; HYDROGEN-ION CONCENTRATION; MALE; MAZE LEARNING; MICE; NANOPARTICLES; NEUROPROTECTIVE AGENTS; PARTICLE SIZE; RABBITS; RATS; RATS, WISTAR; SCOPOLAMINE HYDROBROMIDE; SESQUITERPENES; SKIN; SKIN ABSORPTION; SKIN IRRITANCY TESTS; VISCOSITY;

EID: 84875155310     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.02.014     Document Type: Article

References (30)

1. R. Agrawal, E. Tyagi, G. Saxena, and C. Nath Cholinergic influence on memory stages: a study on scopolamine amnesic mice Indian J. Pharmacol. 41 2009 192 196
2. D.L. Bai, X.C. Tang, and X.C. He Huperzine A, a potential therapeutic agent for treatment of Alzheimer's disease Curr. Med. Chem. 7 2000 355 374
3. K. Bhaskar, C.K. Mohan, M. Lingam, S.J. Mohan, V. Venkateswarlu, and Y.M. Rao Development of SLN and NLC enriched hydrogels for transdermal delivery of nitrendipine: in vitro and in vivo characteristics Drug Dev. Ind. Pharm. 35 2009 98 113
4. H. Chen, D. Mou, D. Du, X. Chang, D. Zhu, J. Liu, H. Xu, and X. Yang Hydrogel-thickened microemulsion for topical administration of drug molecule at an extremely low concentration Int. J. Pharm. 341 2007 78 84
5. D. Chu, J. Tian, W. Liu, Z. Li, and Y. Li Poly (lactic-co-glycolic acid) microspheres for the controlled release of Huperzine A: in vitro and in vivo studies and the application in the treatment of the impaired memory of mice Chem. Pharm. Bull. 55 2007 625 628
6. P. Desai, R.R. Patlolla, and M. Singh Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery Mol. Membr. Biol. 27 2010 247 259
7. J. Draize, G. Woodard, and H. Calvery Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes J. Pharmacol. Exp. Ther. 82 1944 377 390
8. J.Y. Fang, C.L. Fang, C.H. Liu, and Y.H. Su Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC) Eur. J. Pharm. Biopharm. 70 2008 633 640
9. J. Jain, C. Fernandes, and V. Patravale Formulation development of parenteral phospholipid-based microemulsion of etoposide AAPS Pharm. Sci. Technol. 11 2010 826 831
10. M. Joshi, S. Pathak, S. Sharma, and V. Patravale Design and in vivo pharmacodynamic evaluation of nanostructured lipid carriers for parenteral delivery of artemether: Nanoject Int. J. Pharm. 364 2008 119 126
11. H. Joshi, and M. Parle Pharmacological evidences for antiamnesic potentials of Phyllanthusamarus in mice Afr. J. Biomed. Res. 10 2007 165 173
12. M.D. Joshi, and V.B. Patravale Formulation and evaluation of nanostructured lipid carrier (NLC)-based gel of valdecoxib Drug Dev. Ind. Pharm. 32 2006 911 918
13. W. Liu, M. Hu, W. Liu, C. Xue, H. Xu, and X. Yang Investigation of the carbopol gel of solid lipid nanoparticles for the transdermal iontophoretic delivery of triamcinolone acetonide acetate Int. J. Pharm. 364 2008 135 141
14. W.H. Liu, J.L. Song, K. Liu, D.F. Chu, and Y.X. Li Preparation and in vitro and in vivo release studies of Huperzine A loaded microspheres for the treatment of Alzheimer's disease J. Controlled Rel. 107 2005 417 427
15. S.D. Mandawgade, and V.B. Patravale Development of SLNs from natural lipids: application to topical delivery of tretinoin Int. J. Pharm. 363 2008 1 2
16. S. Martins, B. Sarmento, D.C. Ferreira, and E.B. Souto Oral insulin delivery by means of solid lip nanoparticles Int. J. Nanomed. 2 2007 743 749
17. S.N. Murthy, A.B. Nair, N. Hammer, S.R.K. Vaka, and A.E. Wright Dermatokinetics of nanoparticles (25 nm) Int. J. Innov. Pharm. Res. 1 2012 37 43
18. L. Priano, M.R. Gasco, and A. Mauro Transdermal treatment options for neurological disorders: impact on the elderly Drugs Aging 23 2006 357 375
19. T.W. Prow, J.E. Grice, L.L. Lin, R. Faye, M. Butler, and W. Becker Nanoparticles and microparticles for skin drug delivery Adv. Drug Deliv. Rev. 63 2011 470 491
20. J. Shi, W. Cong, Y. Wang, Q. Liu, and G. Luo Microemulsion-based patch for transdermal delivery of Huperzine A and ligustrazine phosphate in treatment of Alzheimer's disease Drug Dev. Ind. Pharm. 38 2012 752 761
21. E.B. Souto, and S. Doktorovova Methods in Enzymology vol. 464 2009 Elsevier Inc. pp. 105-129
22. J.B. Standridge Pharmacotherapeutic approaches to the treatment of Alzheimer's disease Clin. Ther. 26 2004 615 630
23. C. Tan, S. Jiang, and D. Zhu Huperzine A, a novel lycopodium alkaloid from Huperzia serrata Tetrahedron Lett. 41 2000 5733 5736
24. B.A. Toms F.R. Eirich, Rheology: Theory and Applications vol. 2 1958 Academic Press New York 475
25. N. Ustundagokur, S. Apaydinb, N.U. Karabay, A. Yavasoglu, and H.Y. Karasulua Evaluation of skin permeation and anti-inflammatory and analgesic effects of new naproxen microemulsion formulations Int. J. Pharm. 416 2011 136 144
26. B.S. Wang, H. Wang, Z.H. Wei, Y.Y. Song, L. Zhang, and H.Z. Chen Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer's disease: an updated meta-analysis J. Neural Transm. 116 2009 457 465
27. L. Xu, J. Pan, Q. Chen, Q. Yu, H. Chen, H. Xu, Y. Qiu, and X. Yang In vivo evaluation of the safety of triptolide-loaded hydrogel-thickened microemulsion Food Chem. Toxicol. 46 2008 3792 3799
28. J.C. Ye, S. Zeng, G.L. Zheng, and G.S. Chena Pharmacokinetics of Huperzine A after transdermal and oral administration in beagle dogs Int. J. Pharm. 356 2008 187 192
29. H.Y. Zhang, C.Y. Zheng, H.Y. Zhi, F. Wang, L.L. Tang, X. Gao, and X.C. Tang Potential therapeutic targets of huperzine A for Alzheimer's disease and vascular dementia Chem. Biol. Interact. 175 2008 396 402
30. H.Y. Zhang, and X.C. Tang Neuroprotective effects of huperzine A: new therapeutic targets for neurodegenerative disease Trends Pharmacol. Sci. 27 2006 619 635